These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 14657813)

  • 1. N-acetylcysteine does not prevent bronchopulmonary dysplasia in immature infants: a randomized controlled trial.
    Ahola T; Lapatto R; Raivio KO; Selander B; Stigson L; Jonsson B; Jonsbo F; Esberg G; Stövring S; Kjartansson S; Stiris T; Lossius K; Virkola K; Fellman V
    J Pediatr; 2003 Dec; 143(6):713-9. PubMed ID: 14657813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Hydrocortisone Therapy Initiated 7 to 14 Days After Birth on Mortality or Bronchopulmonary Dysplasia Among Very Preterm Infants Receiving Mechanical Ventilation: A Randomized Clinical Trial.
    Onland W; Cools F; Kroon A; Rademaker K; Merkus MP; Dijk PH; van Straaten HL; Te Pas AB; Mohns T; Bruneel E; van Heijst AF; Kramer BW; Debeer A; Zonnenberg I; Marechal Y; Blom H; Plaskie K; Offringa M; van Kaam AH;
    JAMA; 2019 Jan; 321(4):354-363. PubMed ID: 30694322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A controlled trial of dexamethasone to prevent bronchopulmonary dysplasia in surfactant-treated infants.
    Rastogi A; Akintorin SM; Bez ML; Morales P; Pildes RS
    Pediatrics; 1996 Aug; 98(2 Pt 1):204-10. PubMed ID: 8692619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Azithromycin in the extremely low birth weight infant for the prevention of bronchopulmonary dysplasia: a pilot study.
    Ballard HO; Anstead MI; Shook LA
    Respir Res; 2007 Jun; 8(1):41. PubMed ID: 17550598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early postnatal additional high-dose oral vitamin A supplementation versus placebo for 28 days for preventing bronchopulmonary dysplasia or death in extremely low birth weight infants.
    Meyer S; Gortner L;
    Neonatology; 2014; 105(3):182-8. PubMed ID: 24434948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhalation or instillation of steroids for the prevention of bronchopulmonary dysplasia.
    Bassler D
    Neonatology; 2015; 107(4):358-9. PubMed ID: 26044104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-acetylcysteine administration during the first week of life does not improve lung function in extremely low birth weight infants.
    Sandberg K; Fellman V; Stigson L; Thiringer K; Hjalmarson O
    Biol Neonate; 2004; 86(4):275-9. PubMed ID: 15297790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of oestradiol and progesterone replacement on bronchopulmonary dysplasia in extremely preterm infants.
    Trotter A; Maier L; Kron M; Pohlandt F
    Arch Dis Child Fetal Neonatal Ed; 2007 Mar; 92(2):F94-8. PubMed ID: 16905572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The N3RO trial: a randomised controlled trial of docosahexaenoic acid to reduce bronchopulmonary dysplasia in preterm infants < 29 weeks' gestation.
    Collins CT; Gibson RA; Makrides M; McPhee AJ; Sullivan TR; Davis PG; Thio M; Simmer K; Rajadurai VS;
    BMC Pediatr; 2016 Jun; 16():72. PubMed ID: 27250120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of azithromycin for the prevention of bronchopulmonary dysplasia in preterm infants: a randomized, double-blind, placebo controlled trial.
    Ballard HO; Shook LA; Bernard P; Anstead MI; Kuhn R; Whitehead V; Grider D; Crawford TN; Hayes D
    Pediatr Pulmonol; 2011 Feb; 46(2):111-8. PubMed ID: 20963840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between early postnatal weight loss and death or BPD in small and appropriate for gestational age extremely low-birth-weight infants.
    Wadhawan R; Oh W; Perritt R; Laptook AR; Poole K; Wright LL; Fanaroff AA; Duara S; Stoll BJ; Goldberg R
    J Perinatol; 2007 Jun; 27(6):359-64. PubMed ID: 17443198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prophylaxis of early adrenal insufficiency to prevent bronchopulmonary dysplasia: a multicenter trial.
    Watterberg KL; Gerdes JS; Cole CH; Aucott SW; Thilo EH; Mammel MC; Couser RJ; Garland JS; Rozycki HJ; Leach CL; Backstrom C; Shaffer ML
    Pediatrics; 2004 Dec; 114(6):1649-57. PubMed ID: 15574629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of the National Institutes of Health consensus definition of bronchopulmonary dysplasia.
    Ehrenkranz RA; Walsh MC; Vohr BR; Jobe AH; Wright LL; Fanaroff AA; Wrage LA; Poole K;
    Pediatrics; 2005 Dec; 116(6):1353-60. PubMed ID: 16322158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enteral vitamin A for reducing severity of bronchopulmonary dysplasia in extremely preterm infants: a randomised controlled trial.
    Rakshasbhuvankar A; Patole S; Simmer K; Pillow JJ
    BMC Pediatr; 2017 Dec; 17(1):204. PubMed ID: 29246130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nebulized pentoxifylline for reducing the duration of oxygen supplementation in extremely preterm neonates.
    Schulzke SM; Deshmukh M; Nathan EA; Doherty DA; Patole SK
    J Pediatr; 2015 May; 166(5):1158-1162.e2. PubMed ID: 25748566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does the experience with the use of nasal continuous positive airway pressure improve over time in extremely low birth weight infants?
    Aly H; Milner JD; Patel K; El-Mohandes AA
    Pediatrics; 2004 Sep; 114(3):697-702. PubMed ID: 15342841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delivery room continuous positive airway pressure/positive end-expiratory pressure in extremely low birth weight infants: a feasibility trial.
    Finer NN; Carlo WA; Duara S; Fanaroff AA; Donovan EF; Wright LL; Kandefer S; Poole WK;
    Pediatrics; 2004 Sep; 114(3):651-7. PubMed ID: 15342835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hospital variation and risk factors for bronchopulmonary dysplasia in a population-based cohort.
    Lapcharoensap W; Gage SC; Kan P; Profit J; Shaw GM; Gould JB; Stevenson DK; O'Brodovich H; Lee HC
    JAMA Pediatr; 2015 Feb; 169(2):e143676. PubMed ID: 25642906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic Hydrocortisone To Prevent Bronchopulmonary Dysplasia in preterm infants (the SToP-BPD study); a multicenter randomized placebo controlled trial.
    Onland W; Offringa M; Cools F; De Jaegere AP; Rademaker K; Blom H; Cavatorta E; Debeer A; Dijk PH; van Heijst AF; Kramer BW; Kroon AA; Mohns T; van Straaten HL; te Pas AB; Theyskens C; van Weissenbruch MM; van Kaam AH
    BMC Pediatr; 2011 Nov; 11():102. PubMed ID: 22070744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhaled nitric oxide for prevention of bronchopulmonary dysplasia in premature babies (EUNO): a randomised controlled trial.
    Mercier JC; Hummler H; Durrmeyer X; Sanchez-Luna M; Carnielli V; Field D; Greenough A; Van Overmeire B; Jonsson B; Hallman M; Baldassarre J;
    Lancet; 2010 Jul; 376(9738):346-54. PubMed ID: 20655106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.